Relevant bibliographies by topics / Multidrug-resistant tuberculosis – Ethiopia / Journal articles
To see the other types of publications on this topic, follow the link: Multidrug-resistant tuberculosis – Ethiopia.

Journal articles on the topic 'Multidrug-resistant tuberculosis – Ethiopia'

Author: Grafiati
Published: 4 June 2021
Last updated: 1 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Multidrug-resistant tuberculosis – Ethiopia.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Andarge, Degineh Belachew, Tariku Lambiyo Anticho, Getamesay Mulatu Jara, and Musa Mohammed Ali. "Prevalence of Mycobacterium tuberculosis infection and rifampicin resistance among presumptive tuberculosis cases visiting tuberculosis clinic of Adare General Hospital, Southern Ethiopia." SAGE Open Medicine 9 (January 2021): 205031212110455. http://dx.doi.org/10.1177/20503121211045541.

Full text
Abstract:
Objective: Multidrug-resistant Mycobacterium tuberculosis is a public health threat in resource-limited countries where it is easily disseminated and difficult to control. The aim of this study was to determine the prevalence of tuberculosis, rifampicin-resistant/multidrug-resistant Mycobacterium tuberculosis, and associated factors among presumptive tuberculosis cases attending the tuberculosis clinic of Adare General Hospital located in Hawassa city. Methods: A hospital-based cross-sectional study was conducted among 321 tuberculosis suspected patients from April to July 2018. Socio-demograp
APA, Harvard, Vancouver, ISO, and other styles
2

Assefa, Demelash, Berhanu Seyoum, and Lemessa Oljira. "Determinants of multidrug-resistant tuberculosis in Addis Ababa, Ethiopia." Infection and Drug Resistance Volume 10 (July 2017): 209–13. http://dx.doi.org/10.2147/idr.s134369.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Woya, Ashenafi Abate, Abay Kassa Tekile, and Garoma Wakjira Basha. "Spatial Frailty Survival Model for Multidrug-Resistant Tuberculosis Mortality in Amhara Region, Ethiopia." Tuberculosis Research and Treatment 2019 (January 1, 2019): 1–7. http://dx.doi.org/10.1155/2019/8742363.

Full text
Abstract:
Tuberculosis (TB), a disease caused by Mycobacterium tuberculosis (MTB), is the main cause of death. It disproportionally affects those living in the different regions of countries and within the region. The aim of this study was to examine spatial variation of mortality and the risk factor of death on multidrug-resistant tuberculosis patients treated in different MDR-TB hospitals of Amhara region. The data for this study was used from multidrug-resistant tuberculosis patients’ record charts and analyzed using STATA software. The result of this study shows that 61 (29.47%) of the patients died
APA, Harvard, Vancouver, ISO, and other styles
4

Asgedom, Solomon Weldegebreal, Mebrahtu Teweldemedhin, and Hailay Gebreyesus. "Prevalence of Multidrug-Resistant Tuberculosis and Associated Factors in Ethiopia: A Systematic Review." Journal of Pathogens 2018 (2018): 1–8. http://dx.doi.org/10.1155/2018/7104921.

Full text
Abstract:
Background. Multidrug-resistant tuberculosis (MDR-TB) has continued to be a challenge for tuberculosis (TB) control globally. Ethiopia is one of the countries with high MDR-TB burden. Objective. The main purpose of this study was to determine the prevalence of MDR-TB and associated factors in Ethiopia. Methods. A systematic review of the literatures on prevalence of MDR-TB and associated factors was conducted in the country. Results. In our electronic search, 546 citations were depicted. Among the total 546 citations described, a total of 22 articles met eligibility criteria and were included
APA, Harvard, Vancouver, ISO, and other styles
5

Diriba, B., T. Berkessa, G. Mamo, Y. Tedla, and G. Ameni. "Spoligotyping of multidrug-resistant Mycobacterium tuberculosis isolates in Ethiopia." International Journal of Tuberculosis and Lung Disease 17, no. 2 (2013): 246–50. http://dx.doi.org/10.5588/ijtld.12.0195.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Alene, Kefyalew Addis, Kerri Viney, Emma S. McBryde, Adino Tesfahun Tsegaye, and Archie C. A. Clements. "Treatment outcomes in patients with multidrug-resistant tuberculosis in north-west Ethiopia." Tropical Medicine & International Health 22, no. 3 (2017): 351–62. http://dx.doi.org/10.1111/tmi.12826.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Fiseha, D., H. Kumssa, M. Tefera, A. Tesfaye, E. Klinkenberg, and G. Yimer. "Ambulatory care for multidrug-resistant tuberculosis: lessons learned in Addis Ababa, Ethiopia." Public Health Action 4, no. 3 (2014): 37–41. http://dx.doi.org/10.5588/pha.14.0058.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Mekonnen, Daniel, Aschalew Admassu, Wondemagegn Mulu, et al. "Multidrug-resistant and heteroresistant Mycobacterium tuberculosis and associated gene mutations in Ethiopia." International Journal of Infectious Diseases 39 (October 2015): 34–38. http://dx.doi.org/10.1016/j.ijid.2015.06.013.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Mulisa, Girma, Tilaye Workneh, Niguse Hordofa, Mohamed Suaudi, Gemeda Abebe, and Godana Jarso. "Multidrug-resistant Mycobacterium tuberculosis and associated risk factors in Oromia Region of Ethiopia." International Journal of Infectious Diseases 39 (October 2015): 57–61. http://dx.doi.org/10.1016/j.ijid.2015.08.013.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Brhane, Mussie, Ameha Kebede, and Yohannes Petros. "Molecular detection of multidrug-resistant tuberculosis among smear-positive pulmonary tuberculosis patients in Jigjiga town, Ethiopia." Infection and Drug Resistance Volume 10 (March 2017): 75–83. http://dx.doi.org/10.2147/idr.s127903.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Muluneh, Mikyas Arega, Abayneh Birlie Zeru, Behailu Tariku Derseh, and Abebaw Molla Kebede. "Survival Status and Predictors of Mortality among Multidrug-Resistant Tuberculosis Patients in Saint Peter’s Specialized Hospital, Addis Ababa, Ethiopia." Canadian Journal of Infectious Diseases and Medical Microbiology 2021 (September 3, 2021): 1–9. http://dx.doi.org/10.1155/2021/6696199.

Full text
Abstract:
Background. Multidrug-Resistant Tuberculosis (MDR-TB) is tuberculosis that is resistant to at least both rifampicin and isoniazid. The World Health Organization as reported in 2019 revealed that Ethiopia is among the 20 countries with the highest estimated numbers of incident MDR-TB cases. However, supporting evidence is limited in the study area after the Ethiopian national strategic plan for tuberculosis prevention and control is started. Objective. To determine survival status and predictors of mortality among multidrug-resistant tuberculosis patients treated in Saint Peter’s Specialized Ho
APA, Harvard, Vancouver, ISO, and other styles
12

Zewdie, O., A. Mihret, T. Abebe, et al. "Genotyping and molecular detection of multidrug-resistant Mycobacterium tuberculosis among tuberculosis lymphadenitis cases in Addis Ababa, Ethiopia." New Microbes and New Infections 21 (January 2018): 36–41. http://dx.doi.org/10.1016/j.nmni.2017.10.009.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Zewdie, Olifan, Regea Dabsu, Edosa Kifle, and Dechasa Befikadu. "Rifampicin-Resistant Multidrug-Resistant Tuberculosis Cases in Selected Hospitals in Western Oromia, Ethiopia: Cross-Sectional Retrospective Study." Infection and Drug Resistance Volume 13 (October 2020): 3699–705. http://dx.doi.org/10.2147/idr.s274589.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Diriba, Getu, Abebaw Kebede, Habteyes Hailu Tola, et al. "Molecular characterization and drug resistance patterns of Mycobacterium tuberculosis complex in extrapulmonary tuberculosis patients in Addis Ababa, Ethiopia." PLOS ONE 15, no. 12 (2020): e0243493. http://dx.doi.org/10.1371/journal.pone.0243493.

Full text
Abstract:
Background Molecular characterization of Mycobacterium tuberculosis (MTB) is important to understand the pathogenesis, diagnosis, treatment, and prevention of tuberculosis (TB). However, there is limited information on molecular characteristics and drug-resistant patterns of MTB in patients with extra-pulmonary tuberculosis (EPTB) in Ethiopia. Thus, this study aimed to determine the molecular characteristics and drug resistance patterns of MTB in patients with EPTB in Addis Ababa, Ethiopia. Methods This study was conducted on frozen stored isolates of EPTB survey conducted in Addis Ababa, Ethi
APA, Harvard, Vancouver, ISO, and other styles
15

Kusheno, Firew Tadesse, Teklehaimanot Mezgebe Nguse, and Gebremedhin Beedemariam Gebretekle. "Assessment of Knowledge and Attitude of Tuberculosis Patients in Direct Observation Therapy Program towards Multidrug-Resistant Tuberculosis in Addis Ababa, Ethiopia: A Cross-Sectional Study." Tuberculosis Research and Treatment 2020 (June 8, 2020): 1–10. http://dx.doi.org/10.1155/2020/6475286.

Full text
Abstract:
Background. Multidrug-resistant tuberculosis (MDR-TB) is becoming a major challenge of tuberculosis (TB) control program globally but more serious in developing countries like Ethiopia. In 2013, a survey result showed that in Ethiopia, tuberculosis patients from new cases and retreatment cases had resistance to at least isoniazid and rifampicin with a significant increase over time. Inadequate knowledge and wrong perception about MDR-TB by patients were detrimental to TB control programs. The study aimed at assessing the knowledge and attitude of TB patients of direct observation therapy progr
APA, Harvard, Vancouver, ISO, and other styles
16

Tesfay, Kebede, Shinesh Tesfay, Etsay Nigus, Araya Gebreyesus, Dawit Gebreegziabiher, and Kelemework Adane. "More than half of presumptive multidrug-resistant cases referred to a tuberculosis referral laboratory in the Tigray region of Ethiopia are multidrug resistant." International Journal of Mycobacteriology 5, no. 3 (2016): 324–27. http://dx.doi.org/10.1016/j.ijmyco.2016.07.007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Welekidan, Letemichael Negash, Eystein Skjerve, Tsehaye Asmelash Dejene, et al. "Characteristics of pulmonary multidrug-resistant tuberculosis patients in Tigray Region, Ethiopia: A cross-sectional study." PLOS ONE 15, no. 8 (2020): e0236362. http://dx.doi.org/10.1371/journal.pone.0236362.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Diriba, Getu, Abebaw Kebede, Habteyes Hailu Tola, et al. "Mycobacterial Lineages Associated with Drug Resistance in Patients with Extrapulmonary Tuberculosis in Addis Ababa, Ethiopia." Tuberculosis Research and Treatment 2021 (September 18, 2021): 1–7. http://dx.doi.org/10.1155/2021/5239529.

Full text
Abstract:
Background. In Ethiopia, tuberculosis (TB) is one of the most common causes of illness and death. However, there is limited information available on lineages associated with drug resistance among extrapulmonary tuberculosis patients in Ethiopia. In this study, researchers looked into Mycobacterium tuberculosis lineages linked to drug resistance in patients with extrapulmonary tuberculosis in Addis Ababa, Ethiopia. Methods. On 151 Mycobacterium tuberculosis isolates, a cross-sectional analysis was performed. Spoligotyping was used to characterize mycobacterial lineages, while a phenotypic drug
APA, Harvard, Vancouver, ISO, and other styles
19

Reta, Alemayehu, Abebaw Bitew Kifilie, and Abeba Mengist. "Bacterial Infections and Their Antibiotic Resistance Pattern in Ethiopia: A Systematic Review." Advances in Preventive Medicine 2019 (August 5, 2019): 1–10. http://dx.doi.org/10.1155/2019/4380309.

Full text
Abstract:
Background. Antibiotic resistance is a global challenge in the public health sector and also a major challenge in Ethiopia. It is truly difficult to report bacterial antibiotic resistance pattern in Ethiopia due to the absence of a review which is done comprehensively. The aim of this systematic review was to provide an overview of the works of literature on the antibiotic resistance pattern of the specific bacterial isolates that can be obtained from different clinical samples in the context of Ethiopia. Materials and Methods. A web-based search using PubMed, Google Scholar, Hinari, Sci Hub,
APA, Harvard, Vancouver, ISO, and other styles
20

Madan, Jason J., Laura Rosu, Mamo Girma Tefera, et al. "Economic evaluation of short treatment for multidrug-resistant tuberculosis, Ethiopia and South Africa: the STREAM trial." Bulletin of the World Health Organization 98, no. 5 (2020): 306–14. http://dx.doi.org/10.2471/blt.19.243584.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Woldeyohannes, Demelash, Tesfaye Assefa, Rameto Aman, Yohannes Tekalegn, and Zeleke Hailemariam. "Predictors of time to unfavorable treatment outcomes among patients with multidrug resistant tuberculosis in Oromia region, Ethiopia." PLOS ONE 14, no. 10 (2019): e0224025. http://dx.doi.org/10.1371/journal.pone.0224025.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Mehari, Kibriti, Tsehaye Asmelash, Haftamu Hailekiros, et al. "Prevalence and Factors Associated with Multidrug-Resistant Tuberculosis (MDR-TB) among Presumptive MDR-TB Patients in Tigray Region, Northern Ethiopia." Canadian Journal of Infectious Diseases and Medical Microbiology 2019 (September 9, 2019): 1–8. http://dx.doi.org/10.1155/2019/2923549.

Full text
Abstract:
Background. Tuberculosis (TB) is one of the major public health problems. There are alarming reports of increasing multidrug-resistant tuberculosis (MTR-TB) from various parts of the globe, including Ethiopia. This study was designed to determine the prevalence and factors associated with MDR-TB among presumptive MDR-TB cases in Tigray Regional State, Ethiopia. Methods. A cross-sectional study was conducted in Tigray Regional State from 2015 to 2016. Two hundred sputum samples were collected, transported, processed using 2% N-acetyl-L-cysteine-sodium hydroxide, and cultured in LJ medium. Besid
APA, Harvard, Vancouver, ISO, and other styles
23

Shibabaw, Agumas, Baye Gelaw, Shu-Hua Wang, and Belay Tessema. "Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia." PLOS ONE 13, no. 6 (2018): e0198080. http://dx.doi.org/10.1371/journal.pone.0198080.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Alemayehu, Senait, Amanuel Yigezu, Damen Hailemariam, and Alemayehu Hailu. "Cost-effectiveness of treating multidrug-resistant tuberculosis in treatment initiative centers and treatment follow-up centers in Ethiopia." PLOS ONE 15, no. 7 (2020): e0235820. http://dx.doi.org/10.1371/journal.pone.0235820.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Alene, Kefyalew Addis, Kerri Viney, Emma S. McBryde, and Archie C. A. Clements. "Spatial patterns of multidrug resistant tuberculosis and relationships to socio-economic, demographic and household factors in northwest Ethiopia." PLOS ONE 12, no. 2 (2017): e0171800. http://dx.doi.org/10.1371/journal.pone.0171800.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Gebrekidan, Gezahegn, Gezahegn Tesfaye, Mitiku Teshome Hambisa, and Negussie Deyessa. "Quality of Tuberculosis Care in Private Health Facilities of Addis Ababa, Ethiopia." Tuberculosis Research and Treatment 2014 (2014): 1–9. http://dx.doi.org/10.1155/2014/720432.

Full text
Abstract:
Ensuring provision of good quality tuberculosis (TB) care, especially in private for profit health facilities, is an important component of TB control strategy to reduce poor medical practice which results in multidrug resistant TB (MDR-TB). The aim of this study was to investigate quality of TB care in private health facilities of Addis Ababa. A facility based cross-sectional study was conducted based on Donabedian’s structure-process-outcome model of health care quality. Quality of care was determined by adherence to National TB Program guidelines, treatment success rate, and client satisfac
APA, Harvard, Vancouver, ISO, and other styles
27

Getahun, Tefera, and Seid Yimer. "Actual practice of healthcare providers towards prevention and control of Multidrug-resistant tuberculosis (MDR-TB) at Borumeda Hospital, Ethiopia." African Journal of Pharmacy and Pharmacology 11, no. 12 (2017): 152–60. http://dx.doi.org/10.5897/ajpp2015.4402.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Biranu, Endalkchew, Mistire Wolde, Abebe Edao Negesso, Habteyes Hailu Tola, and Million Molla Sisay. "Thyroid Profile and Factors Associated with Hypothyroidism Among Multidrug-Resistant Tuberculosis Patients Attending Saint Peter’s Specialized Hospital Addis Ababa, Ethiopia." Infection and Drug Resistance Volume 14 (July 2021): 2675–84. http://dx.doi.org/10.2147/idr.s310404.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Hiruy, Nebiyu, Muluken Melese, Dereje Habte, et al. "Comparison of the yield of tuberculosis among contacts of multidrug-resistant and drug-sensitive tuberculosis patients in Ethiopia using GeneXpert as a primary diagnostic test." International Journal of Infectious Diseases 71 (June 2018): 4–8. http://dx.doi.org/10.1016/j.ijid.2018.03.011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Alene, Kefyalew Addis, Akilew Awoke Adane, Sisay Yifiru, Bikes Destaw Bitew, Aynishet Adane, and Digsu Negese Koye. "Knowledge and practice of health workers about control and prevention of multidrug-resistant tuberculosis in referral hospitals, Ethiopia: a cross-sectional study." BMJ Open 9, no. 2 (2019): e022948. http://dx.doi.org/10.1136/bmjopen-2018-022948.

Full text
Abstract:
ObjectiveThe aim of this study was to assess the knowledge and practice of health workers about multidrug-resistant tuberculosis (MDR-TB) prevention and control.Study design and settingsA cross-sectional study was conducted at Gondar University Referral Hospital and Felege Hiwot Referral Hospital.ParticipantsRandomly selected health workers (ie, medical doctor, nurse, health officer, pharmacy, medical laboratory and midwifery) were the study participants.Outcome measuresThe main outcomes were knowledge and self-reported practice of health workers about MDR-TB.ResultsA total of 377 health worke
APA, Harvard, Vancouver, ISO, and other styles
31

Gube, Addisu Alemayehu, Megbaru Debalkie, Kalid Seid, et al. "Assessment of Anti-TB Drug Nonadherence and Associated Factors among TB Patients Attending TB Clinics in Arba Minch Governmental Health Institutions, Southern Ethiopia." Tuberculosis Research and Treatment 2018 (2018): 1–7. http://dx.doi.org/10.1155/2018/3705812.

Full text
Abstract:
Background. Tuberculosis (TB) is an infectious disease caused by the bacillus Mycobacterium tuberculosis. Nonadherence to anti-TB treatment may result in the emergence of multidrug-resistant TB, prolonged infectiousness, and poor tuberculosis treatment outcomes. Ethiopia is one of the seven countries that reported lower rates of treatment success (84%). This study assessed anti-TB drug nonadherence and associated factors among TB patients in Arba Minch governmental health institutions. Methods. An institution based cross-sectional study design was conducted from April 15 to May 30, 2017. A sys
APA, Harvard, Vancouver, ISO, and other styles
32

Bezu, Haregewoin, Daniel Seifu, Getnet Yimer, and Tesfamariam Mebrhatu. "Prevalence and Risk Factors of Adverse Drug Reactions Associated Multidrug Resistant Tuberculosis Treatments in Selected Treatment Centers in Addis Ababa Ethiopia." Journal of Tuberculosis Research 02, no. 03 (2014): 144–54. http://dx.doi.org/10.4236/jtr.2014.23018.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Chala, Bayissa, and Ahmedin Usmael. "Prevalence of Multidrug Resistant <i>Mycobacterium tuberculosis</i> among Tuberculosis Patients Admitted to Adama Hospital Medical College, Adama, Ethiopia: A Retrospective Study." Journal of Tuberculosis Research 08, no. 03 (2020): 148–57. http://dx.doi.org/10.4236/jtr.2020.83013.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Molla, Yohannes, Degu Jerene, Ilili Jemal, et al. "The experience of scaling up a decentralized, ambulatory model of care for management of multidrug-resistant tuberculosis in two regions of Ethiopia." Journal of Clinical Tuberculosis and Other Mycobacterial Diseases 7 (May 2017): 28–33. http://dx.doi.org/10.1016/j.jctube.2017.03.001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Tola, Habteyes, K. Holakouie-Naieni, Mohammad Ali Mansournia, et al. "National treatment outcome and predictors of death and treatment failure in multidrug-resistant tuberculosis in Ethiopia: a 10-year retrospective cohort study." BMJ Open 11, no. 8 (2021): e040862. http://dx.doi.org/10.1136/bmjopen-2020-040862.

Full text
Abstract:
ObjectivesTreatment success rate in patients treated for multidrug-resistant tuberculosis (MDR-TB) is low, but predictors of treatment failure and death have been under-reported. Thus, we aimed to determine the national proportion of treatment success rate in the past 10 years and factors that predict treatment failure and death in patients with MDR-TB in Ethiopia.SettingA retrospective cohort study with a 10-years follow-up period was conducted in 42 MDR-TB treatment-initiating centres in Ethiopia.ParticipantsA total of 3395 adult patients with MDR-TB who had final treatment outcome and who w
APA, Harvard, Vancouver, ISO, and other styles
36

Shimeles, Ezra, Fikre Enquselassie, Melaku Tilahun, et al. "Risk Factors for Multidrug-Resistant Tuberculosis and Characteristics of Cases: A Case-Control Study of Patients Attending ALERT General Hospital in Addis Ababa, Ethiopia." Open Journal of Respiratory Diseases 09, no. 01 (2019): 1–17. http://dx.doi.org/10.4236/ojrd.2019.91001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Mulugeta, Shegaze Shimbre, Shibru Degaga Tamiru, Hussen Hebo Sultan, Zerdo Zerihun, Girum Tadele, and Teshome Teklu. "Survival and predictors of mortality from multidrug resistant tuberculosis (MDR-TB) among patients treated at MDR-TB Referal Hospitals in Ethiopia: A retrospective cohort study." Journal of Public Health and Epidemiology 12, no. 1 (2020): 13–21. http://dx.doi.org/10.5897/jphe2019.1129.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Eshetie, Setegn, Feleke Moges, and Mulat Dagnew. "Multidrug-resistant tuberculosis in Ethiopian settings and its association with previous antituberculosis treatment: A systematic review and meta-analysis." International Journal of Mycobacteriology 5 (December 2016): S119—S120. http://dx.doi.org/10.1016/j.ijmyco.2016.09.022.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Desissa, Fanta, Tilaye Workineh, and Takele Beyene. "Risk factors for the occurrence of multidrug-resistant tuberculosis among patients undergoing multidrug-resistant tuberculosis treatment in East Shoa, Ethiopia." BMC Public Health 18, no. 1 (2018). http://dx.doi.org/10.1186/s12889-018-5371-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Alene, Kefyalew Addis, Kerri Viney, Emma S. McBryde, Darren J. Gray, Mulugeta Melku, and Archie C. A. Clements. "Risk factors for multidrug‐resistant tuberculosis in northwest Ethiopia: A case–control study." Transboundary and Emerging Diseases, April 15, 2019. http://dx.doi.org/10.1111/tbed.13188.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Biadglegne, Fantahun, Ulrich Sack, and Arne C. Rodloff. "Multidrug-resistant tuberculosis in Ethiopia: efforts to expand diagnostic services, treatment and care." Antimicrobial Resistance and Infection Control 3, no. 1 (2014). http://dx.doi.org/10.1186/2047-2994-3-31.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Tola, Habteyes H., Kourosh Holakouie-Naieni, Mohammad A. Mansournia, et al. "Intermittent treatment interruption and its effect on multidrug resistant tuberculosis treatment outcome in Ethiopia." Scientific Reports 9, no. 1 (2019). http://dx.doi.org/10.1038/s41598-019-56553-1.

Full text
Abstract:
AbstractTreatment interruption is one of the main risk factors of poor treatment outcome and occurrence of additional drug resistant tuberculosis. This study is a national retrospective cohort study with 10 years follow up period in MDR-TB patients in Ethiopia. We included 204 patients who had missed the treatment at least for one day over the course of the treatment (exposed group) and 203 patients who had never interrupted the treatment (unexposed group). We categorized treatment outcome into successful (cured or completed) and unsuccessful (lost to follow up, failed or died). We described t
APA, Harvard, Vancouver, ISO, and other styles
43

Gobena, Dabesa, Gemechu Ameya, Kinfe Haile, Getaneh Abreha, Yoseph Worku, and Tessema Debela. "Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study." Annals of Clinical Microbiology and Antimicrobials 17, no. 1 (2018). http://dx.doi.org/10.1186/s12941-018-0283-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

van den Hof, Susan, David Collins, Firdaus Hafidz, Demissew Beyene, Aigul Tursynbayeva, and Edine Tiemersma. "The socioeconomic impact of multidrug resistant tuberculosis on patients: results from Ethiopia, Indonesia and Kazakhstan." BMC Infectious Diseases 16, no. 1 (2016). http://dx.doi.org/10.1186/s12879-016-1802-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Sinshaw, Waganeh, Abebaw Kebede, Adane Bitew, et al. "Prevalence of tuberculosis, multidrug resistant tuberculosis and associated risk factors among smear negative presumptive pulmonary tuberculosis patients in Addis Ababa, Ethiopia." BMC Infectious Diseases 19, no. 1 (2019). http://dx.doi.org/10.1186/s12879-019-4241-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Kassa, Getahun Molla, Abilo Tadesse, Yalemzewod Assefa Gelaw, et al. "Predictors of mortality among multidrug-resistant tuberculosis patients in central Ethiopia: a retrospective follow-up study." Epidemiology and Infection 148 (2020). http://dx.doi.org/10.1017/s0950268820002514.

Full text
Abstract:
Abstract The burden of multidrug-resistant tuberculosis (MDR-TB) related to mortality in resource-poor countries remains high. This study aimed to estimate the incidence and predictors of death among MDR-TB patients in central Ethiopia. A retrospective follow-up study was conducted at three hospitals in the Amhara region on 451 patients receiving treatment for MDR-TB from September 2010 to January 2017. Data were collected from patient registration books, charts and computer databases. Data were fitted to a parametric frailty model and survival was expressed as an adjusted hazard ratio (AHR) w
APA, Harvard, Vancouver, ISO, and other styles
47

Mekonnen, Feleke, Belay Tessema, Feleke Moges, Aschalew Gelaw, Setegn Eshetie, and Gemechu Kumera. "Multidrug resistant tuberculosis: prevalence and risk factors in districts of metema and west armachiho, Northwest Ethiopia." BMC Infectious Diseases 15, no. 1 (2015). http://dx.doi.org/10.1186/s12879-015-1202-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Daniel Kahase, Kassu Desta, Zelalem Yaregal, et al. "Mycobacterium Tuberculosis and Nontuberculous Mycobacteria Isolates from Presumptive Pulmonary Tuberculosis Patients Attending A Tertiary Hospital in Addis Ababa, Ethiopia." Ethiopian Journal of Health Sciences 31, no. 1 (2021). http://dx.doi.org/10.4314/ejhs.v31i1.3.

Full text
Abstract:
BACKGROUND፡ Mycobacterial infections are known to cause a public health problem globally. The burden of pulmonary disease from nontuberculous mycobacteria is reportedly on the rise in different parts of the world despite the fact that there is limited data about the disease in sub-Saharan Africa including Ethiopia. Hence, we aimed to assess the magnitude of M. tuberculosis and nontuberculous mycobacteria (NTM) among presumptive pulmonary tuberculosis patients attending St. Paul’s hospital Medical College, Addis Ababa, Ethiopia.METHODS: A cross-sectional study was conducted from June to Septemb
APA, Harvard, Vancouver, ISO, and other styles
49

Titiyos, Addisalem, Degu Jerene, and Fikre Enquselasie. "The yield of screening symptomatic contacts of multidrug-resistant tuberculosis cases at a tertiary hospital in Addis Ababa, Ethiopia." BMC Research Notes 8, no. 1 (2015). http://dx.doi.org/10.1186/s13104-015-1442-z.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Demile, Biresaw, Amare Zenebu, Haile Shewaye, Siqing Xia, and Awoke Guadie. "Risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in a tertiary armed force referral and teaching hospital, Ethiopia." BMC Infectious Diseases 18, no. 1 (2018). http://dx.doi.org/10.1186/s12879-018-3167-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography